Sciwind Biosciences Co., Ltd.(NA931)
A clinical-stage metabolic research drug candidate (GLP-1 agonist) developed for weight loss without muscle loss.
1 Insight
Investment Insights
AI-generated insights about Sciwind Biosciences Co., Ltd. from various financial sources
Wednesday, April 29, 2026
Bullish
Represents the next frontier of metabolic research; however, there is skepticism regarding its profile of weight loss without injections or muscle loss.
Wednesday, April 29, 2026
Bullish
Represents the next frontier of metabolic research; however, there is skepticism regarding its profile of weight loss without injections or muscle loss.